Part 5/11:
This proactive approach mirrors China’s previous success in expanding its electric vehicle industry and is now being applied to the biotech sector. State-led initiatives aim to build a robust innovation ecosystem that reduces reliance on Western firms and establishes China as a competitive force on the global stage.
A Global Strategic Shift and Export Ambitions
Chinese biotech companies are not only focusing on domestic markets but are actively seeking export opportunities. Their cancer treatments, diabetes medications, and weight-loss drugs come at a fraction of Western prices, threatening established pharmaceutical markets. This potential for cost-effective medicines could reshape global drug supply chains, nudging Western companies to either collaborate or compete aggressively.